Serial Number | 98594710 |
Word Mark | BR1DGE |
Filing Date | Tuesday, June 11, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Tuesday, February 25, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Educational services, namely, publication of articles and scientific journals, and arranging and conducting conferences, training, seminars, congresses, podcasts, presentations, and workshops for health care providers, care givers, health care insurers, payers in the healthcare field, patients with Type 1 diabetes and related diseases and disorders, and patients with autoimmune diseases, all the foregoing distributed across multiple forms of transmission media including online via the internet and via social network platforms. |
Description of Mark | The mark consists of the stylized wording "br1dge" where the letters "b," "r," "g," and "e" are in lower case and the number "1" stands between the "r" and the "d." Two conjoined arcs appear above the wording, with the larger arc spanning the letters "r" through "d," and the smaller arc spanning the letters "d" and "g." The letters "b," "r," "g", and "e" are in dark blue, the number "1" is in robin's egg blue, and the letter "d" is in an aquamarine gradient, darker towards the rounded left portion and lighter towards the stem. The larger arc is dark blue above the letter "r," gradating to robin's egg blue above the number "1" and aquamarine above the letter "d." The smaller arc is in an aquamarine gradient, darker above the letter "d" and lighter above the letter "g". |
Pseudo Mark | BRIDGE |
Indication of Colors claimed | The color(s) dark blue, robin's egg blue, and aquamarine is/are claimed as a feature of the mark. |
Goods and Services | Medical services; providing medical and psychological support for healthcare professionals, patients with Type 1 diabetes and related diseases and disorders, and patients with autoimmune diseases and disorders; providing medical information in the fields of prevention and treatment of diabetes, autoimmune diseases and disorders, and diseases and disorders related to Type 1 diabetes; providing a web site featuring data and information regarding Type 1 diabetes, treatment of the disease, burden of the disease, and pathophysiology of the autoimmune nature of the disease; providing medical information to health care providers in the fields of diabetes, autoimmune diseases, and related diseases and disorders, and on the prevention and early diagnosis of asymptomatic Type 1 diabetes; providing medical information via all kinds of media, including online via the internet and via social network platforms in the fields of diabetes and autoimmune diseases to patients, health care professionals, and caregivers. |
International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
US Class Codes | 100, 101, 107 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, June 11, 2024 |
Primary Code | 041 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, June 11, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Sanofi |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Paris 75017 FR |
Event Date | Event Description |
Tuesday, June 11, 2024 | NEW APPLICATION ENTERED |
Wednesday, December 18, 2024 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
Wednesday, December 18, 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Monday, February 10, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Monday, February 10, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, February 11, 2025 | ASSIGNED TO EXAMINER |
Tuesday, February 25, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, February 25, 2025 | NON-FINAL ACTION E-MAILED |
Tuesday, February 25, 2025 | NON-FINAL ACTION WRITTEN |